Skip to main content
Show — Main navigation
Hide — Main navigation
Hair & Scalp
Coping During COVID
Expert Insights in Derm
AAD Summer Meeting
SDPA Fall Conference
AAD VMX 2020
GW Advances in Acne
San Diego Dermatology Symposium
Centers of Excellence
Ocular Symptoms Are Common Among Patients With AD
Findings from a recent study showed patients with moderate to severe atopic dermatitis had a high burden of ocular surface disorders and related symptoms.
Topical Antimicrobial Peptide Improves Dysbiosis in AD
A synthetic indolicidin analogue antimicrobial peptide with activity against Staphylococcus aureus improved dysbiosis but not the clinical signs of atopic dermatitis.
Clinical Trial Shows JAK With Topical Corticosteroids Improves AD
A recent randomized clinical trial showed baricitinib combined with topical corticosteroids improved the signs and symptoms of moderate to severe atopic dermatitis.
Topical PD4 Inhibitor Improves AD
Findings from a recent study showed crisaborole ointment quickly and effectively improved mild to moderate atopic dermatitis among pediatric patients.
Long-term Dupilumab Use Safe and Effective for Refractory AD
Findings from a recent study showed dupilumab was safe and effective for treating treatment-resistant atopic dermatitis over a year in a real-world setting.
Review Highlights Treatment Goals of Infectious Complications of AD
A recent review investigated the mechanisms, diagnosis, and management of infectious complications associated with atopic dermatitis, including the use of antibiotics.
More Evidence Shows TCIs Not Linked to Increase in Keratinocyte Carcinoma Risk
Findings from a recent study suggest that topical calcineurin inhibitors are not associated with an increased risk of keratinocyte carcinomas among adult patients with atopic dermatitis.
Is AD Associated With Cancer?
Findings from two large cohort studies highlighted the potential association between atopic dermatitis (AD), overall and specific cancer risks, and the influence of AD severity on this risk.
Which Systemic Therapies for AD Are More Effective?
A recent meta-analysis and systematic review investigated the effectiveness of systemic treatments for patients with atopic dermatitis, highlighting 2 with potentially better short-term efficacy.
TCI Not Associated With Cancer in Children
Findings from a recent study showed no association between the use of topical tacrolimus and cancer among pediatric patients with atopic dermatitis.
Stay in the know.
The Dermatologist Newsletter
Back to Top